company background image
NRC logo

National Research NasdaqGS:NRC Stock Report

Last Price

US$39.61

Market Cap

US$939.6m

7D

-2.0%

1Y

-7.1%

Updated

28 Mar, 2024

Data

Company Financials

National Research Corporation

NasdaqGS:NRC Stock Report

Market Cap: US$939.6m

NRC Stock Overview

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience.

NRC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health3/6
Dividends2/6

National Research Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for National Research
Historical stock prices
Current Share PriceUS$39.61
52 Week HighUS$47.25
52 Week LowUS$36.21
Beta0.44
1 Month Change-3.11%
3 Month Change0.13%
1 Year Change-7.15%
3 Year Change-17.36%
5 Year Change2.22%
Change since IPO98.05%

Recent News & Updates

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Feb 20
National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Recent updates

National Research's (NASDAQ:NRC) Dividend Will Be $0.12

Feb 20
National Research's (NASDAQ:NRC) Dividend Will Be $0.12

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Dec 13
National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

Oct 01
Many Would Be Envious Of National Research's (NASDAQ:NRC) Excellent Returns On Capital

We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Jul 10
We Think National Research (NASDAQ:NRC) Can Stay On Top Of Its Debt

Why We Like The Returns At National Research (NASDAQ:NRC)

May 04
Why We Like The Returns At National Research (NASDAQ:NRC)

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

Mar 25
Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

Nov 17
National Research (NASDAQ:NRC) Will Pay A Dividend Of $0.12

National Research Corp: Market Is Discounting These Key Factors

Sep 18

National Research declares $0.24 dividend

Aug 23

National Research GAAP EPS of $0.33, revenue of $37.3M

Aug 02

National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Jul 13
National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

May 27
Does National Research (NASDAQ:NRC) Have A Healthy Balance Sheet?

National Research Corp.: Quality/Low Risk On Sale

May 17

The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested

Mar 21
The Trend Of High Returns At National Research (NASDAQ:NRC) Has Us Very Interested

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Feb 11
National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

National Research (NASDAQ:NRC) Is Achieving High Returns On Its Capital

Nov 25
National Research (NASDAQ:NRC) Is Achieving High Returns On Its Capital

Is National Research (NASDAQ:NRC) A Risky Investment?

Nov 02
Is National Research (NASDAQ:NRC) A Risky Investment?

National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

Jul 15
National Research (NASDAQ:NRC) Seems To Use Debt Rather Sparingly

This Is Why We Think National Research Corporation's (NASDAQ:NRC) CEO Might Get A Pay Rise Approved By Shareholders

Jun 16
This Is Why We Think National Research Corporation's (NASDAQ:NRC) CEO Might Get A Pay Rise Approved By Shareholders

National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Jun 04
National Research (NASDAQ:NRC) Knows How To Allocate Capital Effectively

Shareholder Returns

NRCUS HealthcareUS Market
7D-2.0%0.6%0.4%
1Y-7.1%9.5%28.8%

Return vs Industry: NRC underperformed the US Healthcare industry which returned 9.5% over the past year.

Return vs Market: NRC underperformed the US Market which returned 28.8% over the past year.

Price Volatility

Is NRC's price volatile compared to industry and market?
NRC volatility
NRC Average Weekly Movement3.8%
Healthcare Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: NRC has not had significant price volatility in the past 3 months.

Volatility Over Time: NRC's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1981435Mike Hayshttps://www.nrchealth.com

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

National Research Corporation Fundamentals Summary

How do National Research's earnings and revenue compare to its market cap?
NRC fundamental statistics
Market capUS$939.63m
Earnings (TTM)US$30.96m
Revenue (TTM)US$148.58m

30.5x

P/E Ratio

6.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NRC income statement (TTM)
RevenueUS$148.58m
Cost of RevenueUS$56.02m
Gross ProfitUS$92.57m
Other ExpensesUS$61.60m
EarningsUS$30.96m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.30
Gross Margin62.30%
Net Profit Margin20.84%
Debt/Equity Ratio74.9%

How did NRC perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

38%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.